Related Experiment Video
Updated: Mar 22, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Nuclear matrix metalloproteinase-2 in the cardiomyocyte and the ischemic-reperfused heart
Sabina Baghirova1, Bryan G Hughes2, Mathieu Poirier2
1Department of Pharmacology, Cardiovascular Research Institute, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
Abstract:
Matrix metalloproteinases (MMPs) are zinc-dependent proteases involved in intra- and extra-cellular matrix remodeling resulting from oxidative stress injury to the heart. MMP-2 was the first MMP to be localized to the nucleus; however, its biological functions there are unclear. We hypothesized that MMP-2 is present in the nucleus under normal physiological conditions but increases during myocardial ischemia-reperfusion (I/R) injury-induced oxidative stress, proteolyzing nuclear structural proteins. Lamins are intermediate filament proteins that provide structural support to the nucleus and are putative targets of MMP-2. To identify lamin susceptibility to MMP-2 proteolysis, purified lamin A or B was incubated with MMP-2 in vitro. Lamin A, but not lamin B, was proteolysed by MMP-2 into an approximately 50kDa fragment, which was also predicted by in silico cleavage site analysis. Immunofluorescent confocal microscopy and subcellular fractionation showed MMP-2 both in the cytosol and nuclei of neonatal rat ventricular myocytes. Rat hearts were isolated and perfused by the Langendorff method aerobically, or subjected to I/R injury in the presence or absence of o-phenanthroline, an MMP inhibitor. Nuclear fractions extracted from I/R hearts showed increased MMP-2 activity, but not protein level. The level of troponin I, a known sarcomeric target of MMP-2, was rescued in I/R hearts treated with o-phenanthroline, demonstrating the efficacy of MMP inhibition. However, lamin A or B levels remained unchanged in I/R hearts. MMP-2 has a widespread subcellular distribution in cardiomyocytes, including a significant presence in the nucleus. The increase in nuclear MMP-2 activity seen during stunning injury here, indicates yet unknown biological actions, other than lamin proteolysis, which may require more severe ischemia to effect.
Insights
Matrix metalloproteinases (MMPs) increase in heart nuclei during oxidative stress. While MMP-2 targets nuclear proteins like lamin A in vitro, its nuclear function during myocardial ischemia-reperfusion injury remains unclear.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) are crucial for extracellular matrix remodeling, particularly following cardiac oxidative stress.
- MMP-2, a specific MMP, has been detected in the cell nucleus, but its precise nuclear roles are not well understood.
- Nuclear structural proteins, such as lamins, are potential targets for MMP-2 activity during cellular stress.
Purpose of the Study:
- To investigate the presence and activity of MMP-2 in the cardiomyocyte nucleus under normal and ischemia-reperfusion (I/R) injury conditions.
- To determine if MMP-2 proteolyzes nuclear structural proteins, specifically lamins A and B, during myocardial I/R injury.
- To assess the impact of MMP inhibition on nuclear MMP-2 activity and lamin integrity.
Main Methods:
- In vitro digestion assays using purified MMP-2 and lamins A/B to assess cleavage.
- Immunofluorescent confocal microscopy and subcellular fractionation to localize MMP-2 in cardiomyocytes.
- Langendorff perfusion of rat hearts subjected to aerobic conditions or I/R injury, with and without an MMP inhibitor (o-phenanthroline).
- Analysis of nuclear MMP-2 activity, protein levels of MMP-2, troponin I, lamin A, and lamin B in heart tissue.
Main Results:
- MMP-2 proteolyzed lamin A into a ~50kDa fragment in vitro, a process predicted by in silico analysis.
- MMP-2 was localized to both the cytosol and nuclei of neonatal rat ventricular myocytes.
- Nuclear MMP-2 activity increased significantly in hearts subjected to I/R injury, although total protein levels did not change.
- MMP inhibition effectively preserved troponin I levels in I/R hearts but did not alter lamin A or B levels.
- Lamin A and B levels remained unchanged in I/R hearts, suggesting they are not significantly degraded by MMP-2 in vivo during this injury model.
Conclusions:
- MMP-2 exhibits widespread subcellular distribution in cardiomyocytes, including a notable nuclear presence.
- Increased nuclear MMP-2 activity during myocardial stunning suggests uncharacterized biological functions.
- Further investigation is needed to elucidate the specific nuclear roles of MMP-2 during cardiac I/R injury, potentially requiring more severe ischemic conditions for observable lamin proteolysis.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Role of Matrix Metalloproteases in Degradation of ECM

